Lyndsey Knoy, D-ABFT-FT Forensic Scientist Washington State Toxicology Laboratory.

Size: px
Start display at page:

Download "Lyndsey Knoy, D-ABFT-FT Forensic Scientist Washington State Toxicology Laboratory."

Transcription

1 Lyndsey Knoy, D-ABFT-FT Forensic Scientist Washington State Toxicology Laboratory

2 Forensic Toxicology is an interdisciplinary science that analyzes blood, fluid and/or tissues for the presence of alcohol, drugs, or poisons and applies the results of that analysis to answer the question: Did drugs and/or alcohol contribute to a person s impairment and/or their death?

3 WSP FLSB Crime Lab Toxicology Lab Breath Test Section DRE Program

4 Seattle laboratory services WA, AK, OR State Toxicologist Fiona Couper Lab Manager Brianna Peterson QA Manager Amanda Black Technical Lead- Brianne O Reilly 2 Supervisors Brian Capron, Brittany Thomas 14 Toxicologists Support staff

5 State Toxicology Lab Services Medical Examiners and Coroners -Death Investigations Law Enforcement Agencies -DUI and DRE Drug Facilitated Sexual Assaults Liquor and Cannabis Control Board Labor and Industry

6 Death Investigations Overdoses Suicides Poisonings Traffic Fatalities Homicides Undetermined

7 Police Investigations DUI/DRE Drug Investigations Drug Endangered Children Liquor and Cannabis Board Drug Facilitated Sexual Assaults

8 ,947 cases! We receive ~1300 cases/month! 675 from AK, 226 from OR DUI/DRE: 10,272 Top Drugs of 2017: Ethanol THC/COOH-THC Methamphetamine/amphetamine Morphine LK: 1,496 cases! ,617 cases Court Testimony for ,529 hours for 308 appearances LK: 139 hours for 26 cases

9 Sample receipt and log-in (Bob Smith, Former PEC) Data Analysis (Andrew Gingras) Create Report Lab analysis (Katie Harris) Expert Testimony Agency/Prosecutor

10 1. Sample receipt and accession 2. Alcohol analysis 3. Drug screen analysis 4. Confirmation analysis 5. Specialty drug analysis 6. Prepare report 7. Review by supervisors and manager

11 US Postal Service Courier (UPS / FedEx) Hand delivered Campus mail

12 Logged in as they arrive by a PEC Photos are taken of mail packaging and evidence seals Each sample checked for name, agency case#, volume and tampering Each case receives a Unique identifier number (eg. ST ) Maintains chain of custody

13 Each case entered in LIMS database ST# is used to track samples in the laboratory Currently about 80 cases are received daily

14 1. Sample receipt and accession 2. Alcohol analysis 3. Drug screen analysis 4. Confirmation analysis 5. Specialty drug analysis 6. Prepare report 7. Review by supervisors and manager

15 Forensic collection of sample Gray top tube Preservative (NaF) & anticoagulant (C 2 K 2 O 4 ) FDA Regulated Certificates from the manufacturer Experts can testify to hearsay Samples are not clotted Vacuum Expiration Date: refers to vacuum

16 All samples are tested for alcohol (ethanol) Head-Space Gas Chromatography (HS/GC) Run in duplicate Two aliquots Two instruments Different columns Different temperature programs Calibrators for each run Control and negative every ten samples

17 Alcohol is a volatile When heated, volatiles enter the vapor phase Vapor is injected onto a long-thin column Compounds on column separated by physicalchemical properties (size, shape, volatility, charge) Ethanol has a unique retention time Distinguishes between ethanol and other volatiles Isopropanol from swabs Acetone from diabetes

18

19 Calibration curve for both instruments (r ) Controls must be within 10% of the target Blank cannot contain any peaks Results from each case must agree within 10% of the mean from both results Check for other volatiles in sample

20 1. Sample receipt and accession 2. Alcohol analysis 3. Drug screen analysis 4. Confirmation analysis 5. Specialty drug analysis 6. Prepare report 7. Review by supervisors and manager

21 Drug Screening Enzyme Multiplied Immunoassay Technique (EMIT) Chemical lock and key test Qualitative Class, not compound specific Rule in/rule out for major CNS drug categories Each drug has cut-off level: Blood cut off < urine cut-off Drugs may be present below cut-off

22 6 classes screened Cocaine metabolite Opiates Benzodiazepines Barbiturates Cannabinoids Amphetamines 4 classes screened for urine (amphetamines and cannabinoids omitted)

23 Zolpidem Diphenhydramine Dextromethorphan Certain benzodiazepines: Lorazepam, Clonazepam Fentanyl Acidic/Neutral drugs: Anti-seizures, Soma Most synthetics: bath salts, synthetic cannabinoids SSRI drugs: Citalopram, Fluoxetine, Paroxetine, Venlafaxine, Sertraline Most antipsychotics

24 Blood specimens require extraction procedure Calibrators, controls and blank extracted with each set Positive results must be confirmed

25 Alkaline (basic) drug screen Samples are extracted through a series of steps Calibrators, controls and blanks extracted Purifies and concentrates drugs

26 Analysis by Gas Chromatography/Mass Spectrometry (GC/MS and GC/NPD) Separates drugs based on unique chemical properties Provides unique chemical fingerprint for drugs

27 MS NPD

28 BDS Drug Screen Not absolutely comprehensive Also has a cut-off, more sensitive than immunoassay -distinguish specific member of drug class Drugs may be present below cut-off Drugs not confirmed reported as not detected

29 1. Sample receipt and accession 2. Alcohol analysis 3. Drug Screen analysis 4. Confirmation analysis 5. Specialty drug analysis 6. Prepare report 7. Review by supervisors and manager

30 1.Extraction of Sample 2.Analysis of sample using GC/MS; GC/FID; LCMS; LCMSMS

31 1. Sample receipt and accession 2. Alcohol analysis 3. Drug screen analysis 4. Confirmation analysis 5. Specialty drug analysis 6. Prepare report 7. Review by supervisors and manager

32 Specialty Tests for Drugs Some drugs require special extractions for detection THC Cocaine metabolites Some Opiates (morphine, hydromorphone) Some Benzodiazepines (clonazepam) Confirmation by GC/MS, LC/MS, or LC/MS/MS Method of extraction and analysis allows greater sensitivity

33 Analysts must be certified for analysis of these drugs Typically, solid phase extraction (SPE) Blank, calibrators, controls extracted with each set of cases

34 THC 1 ng/ml Zolpidem 0.01 mg/l Cocaine, BZE, cocaethylene 0.01 mg/l Methadone 0.01 mg/l PCP 0.01 mg/l Amines mg/l includes amphetamine, methamphetamine, MDA, MDMA Barbiturates- 0.5 mg/l includes amobarbital, phenobarbital, pentobarbital, secobarbital, butalbital Opiates: morphine, oxymorphone, oxycodone, codeine, hydrocodone= 0.01 mg/l; hydromorphone, 6-AM= 2 ng/ml Benzodiazepines mg/l for diazepam, temazepam, nordiazepam, zopiclone, alprazolam, clonazepam, lorazepam, oxazepam, midazolam, chlordiazepoxide, triazolam, flurazepam, flunitrazepam; 0.02 mg/l for quetiapine

35 Currently, WSTL does not have testing protocols for designer drugs Cases sent to two contract laboratories: NMS Labs (Pennsylvania) AIT Laboratories (Indiana) Cases will be sent to contract lab if indicated on request form and no other drug(s) is detected

36 Refrigerated while not testing Samples removed from fridge only while preparing for tests Evidence maintained in locked personal fridges or in evidence vault

37 1. Sample receipt and accession 2. Alcohol analysis 3. Drug Screen analysis 4. Confirmation analysis 5. Specialty drug analysis 6. Preparation of report 7. Review by supervisors and manager

38 Review all data files from sequence Blanks are blank Negatives have ISTD Calibration curve is acceptable (R ) Controls are within range Identify/quantifies drug(s) present All data is reviewed by other analysts and/or supervisors

39 Report prepared after all testing is completed for each specific case All batches of data peer and supervisor reviewed prior to release All compounds present above level of quantitation are reported 2 tests- screened and confirmed Retention time-matched and fingerprint ID Quantitative vs. Qualitative Quantitative gives value of drug present in blood (0.04 mg/l or 3 ng/ml) Qualitative Positive without level Parent drug and metabolites can be reported Metabolites may or may not be active

40 Analyst, dates, and methodology Any test not performed by the primary analyst is indicated below the specific test result

41 TWO pages! or more Agency owns report

42 Quality Assurance Record keeping, compliance with SOPs, corrective actions Quality Control Proficiency testing (CAP and WSLH), accuracy of test QA/QC system assures results are accurate, precise, and meaningful Calibration Lab accredited by ASCLD/LAB Tox Lab accredited by ABFT and ASCLD/LAB

43 Testimony! Entire state- Breath and blood Alaska- Blood Oregon- Blood Instrument maintenance Continuing Education workshops, seminars, conferences Educating the public high schools, attorney conferences, continuing ed for police agencies, legislature

44 (206)

1/27/ New Release, Quest Diagnostics Nichols Institute, Valencia

1/27/ New Release, Quest Diagnostics Nichols Institute, Valencia NEW TESTS Please Note: Not all test codes assigned to each assay are listed in the table of contents. Please refer to the complete listing on the page numbers indicated. Test Code Test Name Effective Date

More information

Forensic Toxicology Scope of Testing and Detection Limits

Forensic Toxicology Scope of Testing and Detection Limits Forensic Toxicology Scope of Testing and Detection Limits Table of Contents QUALITATIVE ANALYSES... 2 Volatile Screen by GC/FID... 2 Carbon Monoxide by Microdiffusion... 2 Ethylene Glycol by GC/MS... 2

More information

Test Definition: PDSOX Pain Clinic Drug Screen, Chain of Custody, Urine

Test Definition: PDSOX Pain Clinic Drug Screen, Chain of Custody, Urine Reporting Title: Pain Clinic Drug Screen, CoC, U Performing Location: Rochester Specimen Requirements: Container/Tube: Chain-of-Custody Kit (Supply T282) containing the specimen containers, seals, and

More information

Validation of a Benzodiazepine and Z-Drug Method Using an Agilent 6430 LC/MS/MS

Validation of a Benzodiazepine and Z-Drug Method Using an Agilent 6430 LC/MS/MS Validation of a Benzodiazepine and Z-Drug Method Using an Agilent 6430 LC/MS/MS Application Note Forensics Authors Jason Hudson, Ph.D., James Hutchings, Ph.D., and Rebecca Wagner, Ph.D. Virginia Department

More information

Test Definition: PCDSO Pain Clinic Drug Screen, Urine

Test Definition: PCDSO Pain Clinic Drug Screen, Urine Reporting Title: Pain Clinic Drug Screen, U Performing Location: Rochester Specimen Requirements: Collection Container/Tube: Plastic urine container Submission Container/Tube: Plastic, 60-mL urine bottle

More information

September HCMC Toxicology Transition: Additional information and Frequently Asked Questions

September HCMC Toxicology Transition: Additional information and Frequently Asked Questions September 2016 HCMC Toxicology Transition: Additional information and Frequently Asked Questions Many clinicians have asked for more information about the Urine Drug Compliance Analysis (LAB8742) switch

More information

LCMS-8050 Drugs of Abuse: 113 Analytes with Polarity Switching

LCMS-8050 Drugs of Abuse: 113 Analytes with Polarity Switching Liquid Chromatography Mass Spectrometry SSI-LCMS-8 LCMS-8 Drugs of Abuse: Analytes with Polarity Switching LCMS-8 Summary Seventy six analytes and their internal standards are described below. Multiple

More information

Toxicological Investigation of Drug Impaired Driving Toxicology Laboratory Survey

Toxicological Investigation of Drug Impaired Driving Toxicology Laboratory Survey Toxicological Investigation of Drug Impaired Driving Toxicology Laboratory Survey Kayla J. Lowrie, MS, Jennifer Turri, BS, Jill Yeakel, MSFS, Barry K. Logan, PhD, DABFT, Arcadia University, 450 S. Easton

More information

Evaluation of the Impact of Expanding ELISA Screening in DUID Investigations. Aileen Lu*, Karen S. Scott, Aya Chan-Hosokawa, and Barry K.

Evaluation of the Impact of Expanding ELISA Screening in DUID Investigations. Aileen Lu*, Karen S. Scott, Aya Chan-Hosokawa, and Barry K. Evaluation of the Impact of Expanding ELISA Screening in DUID Investigations Aileen Lu*, Karen S. Scott, Aya Chan-Hosokawa, and Barry K. Logan FSF Emerging Forensic Scientist Award Oral Presentation Disclosure

More information

Pinellas County Forensic Laboratory. Annual Report 2006

Pinellas County Forensic Laboratory. Annual Report 2006 Pinellas County Forensic Laboratory Annual Report 26 Published April 27 Analytical Services Provided Post Mortem/Medical Examiner Toxicology Seized Drug (Controlled Substances) Analysis Fire Debris and

More information

ORAL FLUID AS A CHEMICAL TEST FOR THE DRE PROGRAM : HISTORY, THE FUTURE, AND PRACTICAL CONSIDERATIONS

ORAL FLUID AS A CHEMICAL TEST FOR THE DRE PROGRAM : HISTORY, THE FUTURE, AND PRACTICAL CONSIDERATIONS ORAL FLUID AS A CHEMICAL TEST FOR THE DRE PROGRAM : HISTORY, THE FUTURE, AND PRACTICAL CONSIDERATIONS Barry K Logan PhD, DABFT National Director of Forensic Services, NMS Labs Willow Grove PA Disclaimer

More information

Cross-reactivity reactivity in EMIT

Cross-reactivity reactivity in EMIT Blood Drug Analysis at the State Bureau of Investigation Crime Laboratory Richard W. Waggoner, Jr. Sample Requirements 2-10 ml gray top vacutainers At least 10 ml of urine sample for drug facilitated sexual

More information

Laboratory Service Report

Laboratory Service Report 4 05/25/19 Client C702884-DLP ROCHESTER Amphetamines, Confirmation Positive Confirmed POSITIVE by LC-S/S for the following: Amphetamine = 52 ethamphetamine = 124 ethamphetamine exists in the d- and l-isomeric

More information

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: FOURTH QUARTER, 2008 AND 2008 SUMMARY

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: FOURTH QUARTER, 2008 AND 2008 SUMMARY INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: FOURTH QUARTER, 2008 AND 2008 SUMMARY A report from the Office of Epidemiology and Planning Baltimore

More information

Validation Report for the Neogen Fentanyl Kit for ELISA Screening of Whole Blood and Urine Specimens

Validation Report for the Neogen Fentanyl Kit for ELISA Screening of Whole Blood and Urine Specimens Validation Report for the Neogen Fentanyl Kit for ELISA Screening of Whole Blood and Urine Specimens This document describes the validation of a Neogen Fentanyl kit for the semi-quantitative analysis of

More information

The Drug Testing Process. Employer or Practice

The Drug Testing Process. Employer or Practice Disclosures Clinical Professor, Jefferson Medical College BOD MROCC [Medical Review Officer Certification Council] BOD National Sleep Foundation BOD POEMS [Pennsylvania Occupational & Environmental Medicine

More information

Frequently Asked Questions: Opiate Dependency and Methadone Maintenance Treatment program follow-up

Frequently Asked Questions: Opiate Dependency and Methadone Maintenance Treatment program follow-up Frequently Asked Questions: Opiate Dependency and Methadone Maintenance Treatment program follow-up Dr. Bhushan M. Kapur Associate Professor Department of Laboratory Medicine and Pathobiology, Faculty

More information

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE CITY

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE CITY 2009 FINAL REPORT INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE CITY This report was prepared by: Dr. Jose Arbelaez, M.D. of Baltimore Substance Abuse Systems, and Ryan J. Petteway,

More information

LC Application Note. Dangerous driver?

LC Application Note. Dangerous driver? LC Application Note Dangerous driver? www.palsystem.com Dangerous driver? Robert M. Sears 1 ; Kenneth C. Lewis 2 ; and Kim Gamble 3 1 SC Law Enforcement Division, Columbia, SC 29221; 2 OpAns LLC, Durham

More information

Jen L. Schroeder, B.S.

Jen L. Schroeder, B.S. PO Box 20590 Boulder, Colorado 80308 5375 Western Avenue Boulder, Colorado 80301 (303) 440-4500 Fax (303) 440-0668 www.chematox.com EDUCATION Jen L. Schroeder, B.S. Western Kentucky University, Bowling

More information

European Guidelines for Workplace Drug Testing in UrineandOral fluid

European Guidelines for Workplace Drug Testing in UrineandOral fluid EWDTS European Workplace Drug Testing Society European Guidelines for Workplace Drug Testing in UrineandOral fluid 9th EWDTS Symposium in Lisbon Sanna Taskinen Michaela Neuhofer Updating project # 2 Current

More information

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D Director: David J.

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D Director: David J. Drug Adherence Assessment Report Prescribed Medications: NO MEDICATION LIST PROVIDED CONSISTENT RESULTS - REPORTED MEDICATION DETECTED (PARENT DRUG AND/OR METABOLITE) REPORTED PRESCRIPTION FLAG ANTICIPATED

More information

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years Drug Adherence Assessment Report CleanAssure TM (DRIED BLOOD SPOT): Detection Range see NOTES. Prescribed Medications: NO MEDICATION LIST PROVIDED CONSISTENT RESULTS - MEDICATION DETECTED (PARENT DRUG

More information

INTERPATH LABORATORY, INC. TEST UPDATES

INTERPATH LABORATORY, INC. TEST UPDATES EFFECTIVE DATE: February 16, 2016 INTERPATH LABORATORY, INC. TEST UPDATES Please take note of the following test updates and make the appropriate changes in your Interpath Service Manual. Feel free to

More information

Schedule of Accreditation

Schedule of Accreditation Schedule of Accreditation Organisation Name Trading As INAB Reg No Contact Name Address Medical Bureau Of Road Safety 30T Helen Kearns Contact Phone No 01-7165555 Email Website Accreditation Standard Health

More information

Alcohol. Ethanol Highlands Parkway, Suite 100 Smyrna, GA 30082

Alcohol. Ethanol Highlands Parkway, Suite 100 Smyrna, GA 30082 Alcohol The alcohol of interest is ethanol. Ethanol has a sedative effect in the brain. Ethanol intoxication symptoms include blurred vision, slurred speech, poor coordination and difficulty thinking depending

More information

Applications of High Resolution Mass Spectrometry in Forensic Toxicology. Patrick Kyle, PhD.

Applications of High Resolution Mass Spectrometry in Forensic Toxicology. Patrick Kyle, PhD. Applications of High Resolution Mass Spectrometry in Forensic Toxicology Patrick Kyle, PhD pkyle@umc.edu Financial Disclosures Grant/Research Support: None Salary/Consultant Fees: None Board/Committee/Advisory

More information

A Comprehensive Screening of Illicit and Pain Management Drugs from Whole Blood Using SPE and LC/MS/MS

A Comprehensive Screening of Illicit and Pain Management Drugs from Whole Blood Using SPE and LC/MS/MS A Comprehensive Screening of Illicit and Pain Management Drugs from Whole Blood Using SPE and LC/MS/MS Introduction Drug analysis from whole blood is gaining popularity due to a more complete measurement

More information

Proof of Concept for Automated SPE/HPLC/MS/MS Methods to Replace Traditional Immunoassay with MS Confirmation of Driving Under the Influence Samples

Proof of Concept for Automated SPE/HPLC/MS/MS Methods to Replace Traditional Immunoassay with MS Confirmation of Driving Under the Influence Samples Proof of Concept for Automated SPE/HPLC/MS/MS Methods to Replace Traditional Immunoassay with MS Confirmation of Driving Under the Influence Samples Robert M. Sears, Toxicology Technical Leader 1, Kenneth

More information

Physician s Reference for Urine and Blood Drug Testing and Interpretation

Physician s Reference for Urine and Blood Drug Testing and Interpretation Physician s Reference for Urine and Blood Drug Testing and Interpretation DETECTIMED PANEL Urine (test code 70195) Screen Confirmation Screen Confirmation Alcohol Ethanol Amphetamines Amphetamine Methamphetamine

More information

E XCEL LENCE JUST GOT BETTER UCT FORENSICS CLEAN SCREEN XCEL SPE COLUMNS

E XCEL LENCE JUST GOT BETTER UCT FORENSICS CLEAN SCREEN XCEL SPE COLUMNS FORENSICS UCT E XCEL LENCE JUST GOT BETTER CLEAN SCREEN XCEL SPE COLUMNS CLEAN SCREEN XCEL COLUMNS EXTRACTION OF BASIC DRUGS AND METABOLITES FROM URINE/ BLOOD USING SPE CARTRIDGES 130mg Clean Screen Xcel

More information

Laboratory Testing to Support Pain Management: Methods, Concepts and Case Studies

Laboratory Testing to Support Pain Management: Methods, Concepts and Case Studies Laboratory Testing to Support Pain Management: Methods, Concepts and Case Studies Frederick G. Strathmann, PhD, DABCC, (CC,TC) Medical Director, Toxicology Associate Scientific Director of MS ARUP Laboratories

More information

Pain Medication Management Program Monitors Patient Compliance

Pain Medication Management Program Monitors Patient Compliance PeaceHealth Laboratories UPDATE 2014/15 Edition Pain Medication Management Program Monitors Patient Compliance BENEFITS Monitors analgesic medication adherence to ensure patient safety and protect your

More information

Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population

Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population Adam S. Ptolemy 1, Colleen Murray 2, Edward Dunn 3,

More information

European Guidelines for Workplace Drug Testing in Blood and Blood Spots

European Guidelines for Workplace Drug Testing in Blood and Blood Spots EWDTS European Workplace Drug Testing Society European Guidelines for Workplace Drug Testing in Blood and Blood Spots 9th EWDTS Symposium in Lisbon Wim Schielen 29-5-2015, Lisbon Updating project # 2 Current

More information

ChemaTox Blood Drug Testing Matrix (Updated May 24th, 2016)

ChemaTox Blood Drug Testing Matrix (Updated May 24th, 2016) ChemaTox Blood Drug Testing Matrix (Updated May 24th, 2016) Email: DREtox@chematox.com; Phone: (303)440-4500 Always identify any medications/drugs the suspect states they have taken, or that you suspect

More information

Fully Automated Online Sample Preparation and LC-MS/MS Analysis of Drugs of Abuse in Oral Fluids

Fully Automated Online Sample Preparation and LC-MS/MS Analysis of Drugs of Abuse in Oral Fluids PO-CON1753E Fully Automated Online Sample Preparation and LC-MS/MS Analysis of Drugs of Abuse in Oral Fluids ASMS 2017 TP-442 Joshua F. Emory 1, Nathan DeFreitas 2, Michael Roberts 1, Manoj Tyagi 2, M.

More information

Pain Management and Compliance Toxicology. Greg Jellick, MSFS, D-ABFT-FT Technical Director Quality Toxicology San Antonio, TX

Pain Management and Compliance Toxicology. Greg Jellick, MSFS, D-ABFT-FT Technical Director Quality Toxicology San Antonio, TX Pain Management and Compliance Toxicology Greg Jellick, MSFS, D-ABFT-FT Technical Director Quality Toxicology San Antonio, TX Prescription Drug Abuse: A National Problem Prescription drug abuse is a growing

More information

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years Drug Adherence Assessment Report CleanAssure TM (DRIED BLOOD SPOT): Detection Range see NOTES. Prescribed Medications: HYDROMORPHONE (DILAUDID, EXALGO), CYCLOBENZAPRINE (FLEXERIL), METHADONE (METHADOSE),

More information

Urine Drug Testing Methods 3-5

Urine Drug Testing Methods 3-5 Urine Drug Testing Methods 3-5 Type of Test Logistics Pearls Initial Screening Test: Immunoassay Confirmatory Test: Gas chromatography-mass spectrometry (GCMS) + or Liquid chromatography-mass spectrometry

More information

What Your Drug Test Really Means. Krista Beiermann, RN, OHS Occupational Health Services, Columbus Hospital

What Your Drug Test Really Means. Krista Beiermann, RN, OHS Occupational Health Services, Columbus Hospital What Your Drug Test Really Means Krista Beiermann, RN, OHS Occupational Health Services, Columbus Hospital Disclosure There are no relevant financial relationships with commercial interests associated.

More information

CDIA TM Marijuana Colloidal Gold Test Cassette (Saliva)

CDIA TM Marijuana Colloidal Gold Test Cassette (Saliva) CDIA TM Marijuana Colloidal Gold Test Cassette (Saliva) Cat. No.: DTSJZ023 Pkg. Size: Intended Use The CDIA TM Marijuana Colloidal Gold Test Cassette (Saliva) is an immunochromatography based one step

More information

VIRGINIA DEPARTMENT OF HEALTH OFFICE OF THE CHIEF MEDICAL EXAMINER

VIRGINIA DEPARTMENT OF HEALTH OFFICE OF THE CHIEF MEDICAL EXAMINER VIRGINIA DEPARTMENT OF HEALTH OFFICE OF THE CHIEF MEDICAL EXAMINER To promote and protect the health of all Virginians Fatal Drug Overdose Quarterly Report Edition 216.3 Publication Date: January 217 METHODS,

More information

Drug Profiles of Apprehended Drivers in Victoria

Drug Profiles of Apprehended Drivers in Victoria Drug Profiles of Apprehended Drivers in Victoria J Gerostamoulos, P McCaffrey, O H. Drummer and M Odell*. Victorian Institute of Forensic Medicine, Department of Forensic Medicine, Monash University, 57-83

More information

A Simple and Accurate Method for the Rapid Quantitation of Drugs of Abuse in Urine Using Liquid Chromatography

A Simple and Accurate Method for the Rapid Quantitation of Drugs of Abuse in Urine Using Liquid Chromatography Application Note LCMS-109 A Simple and Accurate Method for the Rapid Quantitation of Drugs of Abuse in Urine Using Liquid Chromatography Time of Flight (LC-TOF) Mass Spectrometry Introduction Many clinical

More information

Effective Date: Approved by: Laboratory Executive Director, Ed Hughes (electronic signature)

Effective Date: Approved by: Laboratory Executive Director, Ed Hughes (electronic signature) 1 Policy #: 803 (PLH-803-02) Effective Date: NA Reviewed Date: 4/11/2008 Subject: URINE DRUG SCREENS Approved by: Laboratory Executive Director, Ed Hughes (electronic signature) Approved by: Laboratory

More information

Pain Medication Management Program Supports Patient Outcomes and Adherence

Pain Medication Management Program Supports Patient Outcomes and Adherence PeaceHealth Laboratories UPDATE 2015 Revised Edition Pain Medication Management Program Supports Patient Outcomes and Adherence BENEFITS Monitors analgesic medication adherence to ensure patient safety

More information

LABORATORY TECHNICAL SPECIFICATIONS MANUAL

LABORATORY TECHNICAL SPECIFICATIONS MANUAL LABORATORY TECHNICAL SPECIFICATIONS MANUAL Produced by Synergy Health Laboratory Services Controlled Document ID 103.00250 January 2015 - Version 9 Purpose of Procedure This document outlines the technical

More information

An Introduction to Forensic Toxicology

An Introduction to Forensic Toxicology An Introduction to Forensic Toxicology Jennifer Shea, PhD, FCACB Ken Obenson, MBBS MFFLM (UK) FRCPC (Anat) FRCPC (Forensic Path) Dip American Brd of Path (Anat & Clin/Cytopath/Forensic Path) April 11,

More information

Linking Opioid Treatment in Primary Care. Roxanne Lewin M.D.

Linking Opioid Treatment in Primary Care. Roxanne Lewin M.D. Roxanne Lewin M.D. The Facts Fewer than 10 percent of individuals with an alcohol use disorder and only about 20 percent of individuals with an opioid use disorder receive specialty treatment. Many individuals

More information

Urine Opioid Dependency Panel (UODP) 1

Urine Opioid Dependency Panel (UODP) 1 Drug Testing Panels Urine Opioid Dependency Panel (UODP) 1 Amphetamines Amphetamine Methamphetamine Methylenedioxyamphetamine Adderall, Dexedrine, Vyvanse, Lisdexamfetamine (Speed, Bennies, Crystal Meth,

More information

Rapid LC/TOF MS for Analytical Screening of Drugs in the Clinical Research Lab

Rapid LC/TOF MS for Analytical Screening of Drugs in the Clinical Research Lab Application Note Clinical Research Rapid LC/TOF MS for Analytical Screening of Drugs in the Clinical Research Lab Authors Adam Barker 1,2, Frederick G. Strathmann 3, Natalie N. Rasmussen 4, and Carrie

More information

Welcome - SAMHSA s Role. Welcome SAMHSA Key Messages 4. Welcome SAMHSA s Direction

Welcome - SAMHSA s Role. Welcome SAMHSA Key Messages 4. Welcome SAMHSA s Direction Welcome - SAMHSA s Role 2 Welcome and Opening Remarks The National Conference on Substance Abuse, Child Welfare and the Courts Division of Workplace Programs Ron R. Flegel, BSMT, M.S. and Charles Lodico,

More information

POINT OF CARE TESTING

POINT OF CARE TESTING POINT OF CARE TESTING POINT OF CARE INSTANT TESTING Randox Testing Services offers a wide range of products to enable you to carry out on-site drug and alcohol testing for instant results. Our products

More information

LABORATORY TECHNICAL SPECIFICATIONS MANUAL

LABORATORY TECHNICAL SPECIFICATIONS MANUAL LABORATORY TECHNICAL SPECIFICATIONS MANUAL Produced by Synergy Health Laboratory Services Controlled Document ID 103.00250 August 2015 - Version 12 Purpose of Procedure This document outlines the technical

More information

DrugSmartCup & DrugSmartDip Accuracy Report as produced by Ameditech, Inc.

DrugSmartCup & DrugSmartDip Accuracy Report as produced by Ameditech, Inc. Accuracy The accuracy of the DrugSmart Drugs of Abuse Tests was evaluated in comparison to commercially available drug screen tests. Sixty (60) negative urine samples collected from presumed non-user volunteers

More information

Jonathan Rochon, Pier-Luc Plante, Serge Auger, Réal Paquin, Jacques Corbeil, Pierre Picard

Jonathan Rochon, Pier-Luc Plante, Serge Auger, Réal Paquin, Jacques Corbeil, Pierre Picard Dried Blood Spots in Tips Targeted Drug Screening in 9 Seconds per Sample Using Laser Diode Thermal Desorption Mass Spectrometry (LDTD-MS/MS) Jonathan Rochon, Pier-Luc Plante, Serge Auger, Réal Paquin,

More information

The Drug Evaluation and Classification Program

The Drug Evaluation and Classification Program The Drug Evaluation and Classification Program International Association of Chiefs of Police Drug Evaluation and Classification (DEC) Program The Drug Evaluation and Classification (DEC) Program is a transportation

More information

WELCOME! 12/13/2018. Today s Topic: Urine Drug Screens in OUD Treatment UW PACC

WELCOME! 12/13/2018. Today s Topic: Urine Drug Screens in OUD Treatment UW PACC Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences 12/13/2018 WELCOME! Today s Topic: Urine Drug Screens in OUD Treatment Should I test and how should I do drug testing

More information

Urine Drug Screening: The Essentials of Interpretation

Urine Drug Screening: The Essentials of Interpretation Urine Drug Screening: The Essentials of Interpretation Loralie J Langman, PhD DABCC (CC, MD, TC), F-ABFT Director Clinical and Forensic Toxicology Laboratory, Mayo Clinic Professor, Mayo Clinic College

More information

Procedure for Toxicology Analysis Version 4 Toxicology Unit Effective Date: 05/10/2013. Toxicology Analysis

Procedure for Toxicology Analysis Version 4 Toxicology Unit Effective Date: 05/10/2013. Toxicology Analysis Toxicology Analysis 1.0 Purpose - This procedure specifies the required elements for analyzing toxicology submissions and reporting the results of the analysis. 2.0 Scope This procedure applies to all

More information

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Schedule of ccreditation United Kingdom ccreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK ccredited to Laboratory locations: Gavenny Court Brecon Road bergavenny Monmouthshire

More information

Pharmacokinetics and Disposition of UDM Comparison of Various Sources for Drug Testing: Urine, Blood, Hair, Saliva. Edward J. Cone, Ph.D.

Pharmacokinetics and Disposition of UDM Comparison of Various Sources for Drug Testing: Urine, Blood, Hair, Saliva. Edward J. Cone, Ph.D. Pharmacokinetics and Disposition of UDM Comparison of Various Sources for Drug Testing: Urine, Blood, Hair, Saliva Edward J. Cone, Ph.D. Johns Hopkins School of Medicine, Baltimore, MD & ConeChem Research,

More information

Learning Objectives. Drug Testing 10/17/2012. Utilization of the urine drug screen: The good, the bad, and the ugly

Learning Objectives. Drug Testing 10/17/2012. Utilization of the urine drug screen: The good, the bad, and the ugly Utilization of the urine drug screen: The good, the bad, and the ugly Jennifer A. Lowry, MD Chief, Section of Medical Toxicology Children s Mercy Hospital Kansas City, MO Learning Objectives Describe the

More information

Contract No. 952-M1 Collection Service Requirements Texas Department of Criminal Justice (TDCJ)

Contract No. 952-M1 Collection Service Requirements Texas Department of Criminal Justice (TDCJ) The services and requirements referenced are specific to Texas Department of Criminal Justice (TDCJ) and are in addition to and may include the services and must be in compliance with the requirements

More information

nextgen precision Test Report

nextgen precision Test Report nextgen precision TM Test Report SUMMARY OF PRECISION S NEXTGEN TEST REPORT In an effort to provide as much clinical insight as possible to our providers, we created our comprehensive NextGen Precision

More information

Identification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities

Identification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities Identification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities Svetla Slavova, PhD Sara LaMantia, MS Terry Bunn, PhD Tracey Corey, MD 2016 Safe States Annual Meeting April 13, 2016, Albuquerque,

More information

LABORATORY TECHNICAL SPECIFICATIONS MANUAL

LABORATORY TECHNICAL SPECIFICATIONS MANUAL LABORATORY TECHNICAL SPECIFICATIONS MANUAL Produced by Controlled Document ID 103.0025 November 2017 Version 17 Ltd Gavenny Court, Brecon Road, Abergavenny, Monmouthshire NP7 7RX, United Kingdom Limited

More information

Fastect II Drug Screen Dipstick Test Training and Certification Program

Fastect II Drug Screen Dipstick Test Training and Certification Program Fastect II Drug Screen Dipstick Test Training and Certification Program Fastect II Training Page 1 of 7 Rev. B Fastect II Drug Screen Dipstick Test Training and Certification for Test Administrators The

More information

Urine Drug Testing. Methadone/Buprenorphine 101 Workshop. Ron Joe, MD, DABAM December 10, 2016

Urine Drug Testing. Methadone/Buprenorphine 101 Workshop. Ron Joe, MD, DABAM December 10, 2016 Urine Drug Testing Methadone/Buprenorphine 101 Workshop Ron Joe, MD, DABAM December 10, 2016 Learning objectives Clarify the purpose of urine drug testing (UDT) Distinguish between UDT for detection of

More information

Quantitative Analysis of Drugs of Abuse in Urine using UHPLC Coupled to Accurate Mass AxION 2 TOF Mass Spectrometer

Quantitative Analysis of Drugs of Abuse in Urine using UHPLC Coupled to Accurate Mass AxION 2 TOF Mass Spectrometer application Note Liquid Chromatography/ Mass Spectrometry Authors Sharanya Reddy Blas Cerda PerkinElmer, Inc. Shelton, CT USA Quantitative Analysis of Drugs of Abuse in Urine using UHPLC Coupled to Accurate

More information

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative The SCE Narrative is written by the Sentinel Community Epidemiologist (SCE) and provides

More information

EDUCATIONAL COMMENTARY rd TEST EVENT Chemistry Urine Drug Testing

EDUCATIONAL COMMENTARY rd TEST EVENT Chemistry Urine Drug Testing EDUCATIONAL COMMENTARY 2003 3 rd TEST EVENT Chemistry Urine Drug Testing Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE

More information

T2007 Seattle, Washington

T2007 Seattle, Washington T2007 Seattle, Washington Application of Liquid Chromatography-Mass Spectrometry with Atmospheric Pressure Chemical Ionization as a Screening Method for forty-two Date-Rape Drugs Piotr Adamowicz*, Maria

More information

Community Drug Early Warning System (CDEWS-3): Washington, DC - Site 3 of 4

Community Drug Early Warning System (CDEWS-3): Washington, DC - Site 3 of 4 Community Drug Early Warning System (CDEWS-3): Washington, DC - Site 3 of 4 Office of National Drug Control Policy Executive Office of the President May 2017 ACKNOWLEDGMENTS This report was funded by Cooperative

More information

Drug Adherence Assessment Report

Drug Adherence Assessment Report Prescribed Medications: Drug Adherence Assessment Report FENTANYL, OXYCODONE CONSISTENT RESULTS - REPORTED MEDICATION DETECTED (PARENT DRUG AND/OR METABOLITE) REPORTED ANTICIPATED TEST PRESCRIPTION (S)

More information

PARTICIPANT GENERAL INFORMATION

PARTICIPANT GENERAL INFORMATION PARTICIPANT GENERAL INFORMATION Instructions: Please complete entire form (print) First name: Last Name: Other names used: Street address: City/State/Zip: County: Region: East TN Middle West Social Security

More information

Drugs of Abuse I Serum

Drugs of Abuse I Serum Drugs of Abuse I Serum 2017-11 1.10 For quality monitoring of quantitative measurements by chromatographic methods These reference materials are produced on the basis of human matrices. The highly accurate

More information

Substance Abuse Testing Electronic Result Reporting Layout Specifications. Version 3.2 January 2004

Substance Abuse Testing Electronic Result Reporting Layout Specifications. Version 3.2 January 2004 Substance Abuse Testing Electronic Result Reporting Layout Specifications Version 3.2 January 2004 Copyright Notice This publication is produced and distributed by LabOne, Inc. to specify the content and

More information

DOF. Scheme Description. Drugs in Oral Fluid Scheme

DOF. Scheme Description. Drugs in Oral Fluid Scheme DOF Drugs in Oral Fluid Scheme Scheme Description LGC Standards Proficiency Testing 1 Chamberhall Business Park Chamberhall Green Bury Lancashire BL9 0AP United Kingdom Telephone: +44 (0) 161 762 2500

More information

Urine Drug Testing to Monitor Opioid Use In Managing Chronic Pain

Urine Drug Testing to Monitor Opioid Use In Managing Chronic Pain Faculty Disclosure Henry C. Nipper, PhD, DABCC Dr. Nipper has listed no financial interest/arrangement that would be considered a conflict of interest. Urine Drug Testing to Monitor Opioid Use In Managing

More information

Comparison of Different Whole Blood Sample Pretreatment Methods for Targeted Analysis of Basic Drugs

Comparison of Different Whole Blood Sample Pretreatment Methods for Targeted Analysis of Basic Drugs Seyed Sadjadi, Shahana Huq, Sean Orlowicz and Laura Snow Phenomenex, Inc., 411 Madrid Ave., Torrance, CA 90501 USA Comparison of Different Whole Blood Sample Pretreatment Methods for Targeted Analysis

More information

[ APPLICATION NOTE ] APPLICATION BENEFITS INTRODUCTION WATERS SOLUTIONS KEYWORDS

[ APPLICATION NOTE ] APPLICATION BENEFITS INTRODUCTION WATERS SOLUTIONS KEYWORDS A Comprehensive Method for the Analysis of Pain Management Drugs and Drugs of Abuse Incorporating Simplified, Rapid Mixed-Mode SPE with UPLC-MS/MS for Clinical Research Jonathan P. Danaceau, Scott Freeto,

More information

C O P E. Milwaukee County Opioid-Related Overdose Report MILWAUKEE COMMUNITY OPIOID PREVENTION EFFORT

C O P E. Milwaukee County Opioid-Related Overdose Report MILWAUKEE COMMUNITY OPIOID PREVENTION EFFORT Milwaukee County Opioid-Related Overdose Report 2012 2016 MILWAUKEE C O P E COMMUNITY OPIOID PREVENTION EFFORT For additional information or if you have questions about the data presented in this report,

More information

Caring for ME Webinar: Urine Drug Screening Speaker: Dr. Jonathan Fellers Tuesday, November 20, PM

Caring for ME Webinar: Urine Drug Screening Speaker: Dr. Jonathan Fellers Tuesday, November 20, PM Caring for ME Webinar: Urine Drug Screening Speaker: Dr. Jonathan Fellers Tuesday, November 20, 2018 12 1 PM Audio is available through your computer speakers. Mission Maine Quality Counts is a nonprofit

More information

Urine Drug Analysis Test No Summary Report

Urine Drug Analysis Test No Summary Report Collaborative Testing Services, Inc FORENSIC TESTING PROGRAM Urine Drug Analysis Test No. 15-5671 Summary Report This test was sent to 72 participants. Each sample set contained three cases with individual

More information

Bree Collaborative AMDG Opioid Prescribing Guidelines Workgroup. Opioid Prescribing Metrics - DRAFT

Bree Collaborative AMDG Opioid Prescribing Guidelines Workgroup. Opioid Prescribing Metrics - DRAFT Bree Collaborative AMDG Opioid Prescribing Guidelines Workgroup Opioid Prescribing Metrics - DRAFT Definitions: Days Supply: The total of all opioid prescriptions dispensed during the calendar quarter

More information

Prepared by Date Adopted Supersedes Procedure # Review Date Revision Date Signature. Distributed to # of Copies Distributed to # of Copies

Prepared by Date Adopted Supersedes Procedure # Review Date Revision Date Signature. Distributed to # of Copies Distributed to # of Copies Procedure: Status DS Prepared by Date Adopted Supersedes Procedure # Review Date Revision Date Signature Distributed to # of Copies Distributed to # of Copies PRINCIPLE: The Status DS 10 Panel (MET/OPI/COC/THC/PCP/BZO/BAR/MTD/TCA/AMP)

More information

Welcome! Supreme Court of Ohio Specialized Dockets Conference. October 23-24, 2017

Welcome! Supreme Court of Ohio Specialized Dockets Conference. October 23-24, 2017 Welcome! Supreme Court of Ohio Specialized Dockets Conference October 23-24, 2017 Drug Testing: Do you know enough to be dangerous? Presented by William L. Parker President & CEO American Court & Drug

More information

Cozart DDS Drug Detection System On-site Saliva Drug Testing

Cozart DDS Drug Detection System On-site Saliva Drug Testing Cozart DDS Drug Detection System On-site Saliva Drug Testing www.siemens.com Siemens Healthcare Diagnostics Drug Testing, under the Cozart brand name, has more than a 10-year legacy of providing an extensive

More information

Toxicology 101. Arizona Problem Solving Courts April 25, 2016

Toxicology 101. Arizona Problem Solving Courts April 25, 2016 Toxicology 101 Arizona Problem Solving Courts April 25, 2016 Aaron Brown, Ph.D. Technical Group Lead Norchem Drug Testing Laboratory Cordant Health Solutions Flagstaff, Arizona Toxicology Toxicology is

More information

METHAMPHETAMINE & AMPHETAMINE

METHAMPHETAMINE & AMPHETAMINE METHAMPHETAMINE & AMPHETAMINE Enantiomers from Urine Rapid and Accurate Chiral Separation Polysaccharide Chiral Chiral LC LC Columns and SFC PHEN-RUO-49 Revision: Lux 3 µm AMP Column High Efficiency LC/MS/MS

More information

Controlled Substance Monitoring in the Age of the Opioid Epidemic

Controlled Substance Monitoring in the Age of the Opioid Epidemic Controlled Substance Monitoring in the Age of the Opioid Epidemic Paul E. Hilliard, MS, MD Hospital Pain Committee Chair Department of Anesthesiology CME housekeeping I have no financial disclosures AKA,

More information

DrugConfirm Advanced Instant Urine Drug Test Cups Training Guide.

DrugConfirm Advanced Instant Urine Drug Test Cups Training Guide. DrugConfirm Advanced Instant Urine Drug Test Cups Training Guide The information in this presentation is a general overview on using Confirm BioSciences DrugConfirm Advanced urine drug test cup; however,

More information

Oxymorphone Distribution in Biological Matrices: A Collection of Case Studies

Oxymorphone Distribution in Biological Matrices: A Collection of Case Studies Oxymorphone Distribution in Biological Matrices: A Collection of Case Studies Brian Simons, Forensic Toxicologist Montgomery County Coroner s Office / Miami Valley Regional Crime Laboratory May 1, 2008

More information

Procedure for Toxicology Analysis Version 7 Toxicology Unit Effective Date: 03/14/2014 Issued by Drug Chemistry Forensic Scientist Manager

Procedure for Toxicology Analysis Version 7 Toxicology Unit Effective Date: 03/14/2014 Issued by Drug Chemistry Forensic Scientist Manager Toxicology Analysis 1.0 Purpose - This procedure specifies the required elements for analyzing toxicology submissions and reporting drug testing results. 2.0 Scope This procedure applies to all submissions

More information

The Prevalence of Marijuana in Suspected Impaired Driving Cases in Washington State

The Prevalence of Marijuana in Suspected Impaired Driving Cases in Washington State Journal of Analytical Toxicology 2014;38:569 574 doi:10.1093/jat/bku090 Special Issue The Prevalence of Marijuana in Suspected Impaired Driving Cases in Washington State Fiona J. Couper* and Brianna L.

More information

Intercept i2he Opiate Oral Fluid Assay

Intercept i2he Opiate Oral Fluid Assay FOR FORENSIC USE ONLY For Use with Oral Fluid Collection Device 1001-0387 (65 ml Kit) INTENDED USE The is intended for use in the qualitative determination of Opiate in human oral fluid at a cutoff concentration

More information

Determination of 78 Banned or Controlled Racing Industry Drugs in Horse Urine Using SPE and LC-MS/MS

Determination of 78 Banned or Controlled Racing Industry Drugs in Horse Urine Using SPE and LC-MS/MS Determination of 78 Banned or Controlled Racing Industry Drugs in Horse Urine Using SPE and LC-MS/MS UCT Part Numbers XRDAH203 Gravity Flow XtrackT DAU 200 mg, 3 ml column SPHPHO6001-5 Select ph Buffer

More information

2015 Annual Physician Notice

2015 Annual Physician Notice 0 Annual Physician Notice The Office of Inspector General (OIG) recommends clinical laboratories send notices to physicians and other providers who use their services, at least once a year, to inform the

More information